Jeffrey Garro
Stock Analyst at Stephens
(0.06)
# 4,308
Out of 4,339 analysts
80
Total ratings
29.9%
Success rate
-25.6%
Average return
Main Sectors:
Stocks Rated by Jeffrey Garro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OPRX OptimizeRx | Rated: Hold | $10 → $7 | $4.83 | +44.93% | 6 | May 13, 2026 | |
| HCAT Health Catalyst | Maintained: Hold | $5 → $1.75 | $1.26 | +38.89% | 4 | May 12, 2026 | |
| CERT Certara | Maintained: Buy | $12 → $9 | $5.21 | +72.74% | 6 | May 12, 2026 | |
| TBRG TruBridge | Maintained: Hold | $18 | $25.95 | -30.64% | 8 | Apr 13, 2026 | |
| PHR Phreesia | Maintained: Buy | $37 → $20 | $8.95 | +123.46% | 3 | Mar 31, 2026 | |
| DH Definitive Healthcare | Maintained: Hold | $5 → $3 | $0.9027 | +232.34% | 2 | Feb 27, 2026 | |
| EVH Evolent Health | Maintained: Buy | $7 | $3.83 | +82.77% | 4 | Feb 25, 2026 | |
| SLP Simulations Plus | Maintained: Buy | $28 → $20 | $15.28 | +30.89% | 3 | Jul 15, 2025 | |
| TDOC Teladoc Health | Maintained: Hold | $8 | $6.59 | n/a | 1 | Apr 30, 2025 | |
| PRVA Privia Health Group | Maintained: Buy | $26 → $30 | $22.20 | n/a | 3 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $13 → $7 | $4.75 | n/a | 9 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $255 → $250 | $162.00 | n/a | 3 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $280 | $158.54 | n/a | 1 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $55 | $19.52 | n/a | 1 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $20 | $16.03 | n/a | 5 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $5 → $3.9 | $7.34 | n/a | 8 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 → $3 | $1.01 | n/a | 7 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $193.06 | n/a | 1 | Dec 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | - | n/a | 5 | May 6, 2020 |
OptimizeRx
May 13, 2026
Rated: Hold
Price Target: $10 → $7
Current: $4.83
Upside: +44.93%
Health Catalyst
May 12, 2026
Maintained: Hold
Price Target: $5 → $1.75
Current: $1.26
Upside: +38.89%
Certara
May 12, 2026
Maintained: Buy
Price Target: $12 → $9
Current: $5.21
Upside: +72.74%
TruBridge
Apr 13, 2026
Maintained: Hold
Price Target: $18
Current: $25.95
Upside: -30.64%
Phreesia
Mar 31, 2026
Maintained: Buy
Price Target: $37 → $20
Current: $8.95
Upside: +123.46%
Definitive Healthcare
Feb 27, 2026
Maintained: Hold
Price Target: $5 → $3
Current: $0.9027
Upside: +232.34%
Evolent Health
Feb 25, 2026
Maintained: Buy
Price Target: $7
Current: $3.83
Upside: +82.77%
Simulations Plus
Jul 15, 2025
Maintained: Buy
Price Target: $28 → $20
Current: $15.28
Upside: +30.89%
Teladoc Health
Apr 30, 2025
Maintained: Hold
Price Target: $8
Current: $6.59
Upside: n/a
Privia Health Group
Mar 5, 2025
Maintained: Buy
Price Target: $26 → $30
Current: $22.20
Upside: n/a
Jan 31, 2025
Maintained: Hold
Price Target: $13 → $7
Current: $4.75
Upside: n/a
Dec 19, 2024
Initiated Coverage: Buy
Price Target: $255 → $250
Current: $162.00
Upside: n/a
Dec 19, 2024
Initiated Coverage: Buy
Price Target: $280
Current: $158.54
Upside: n/a
Dec 19, 2024
Initiated Coverage: Hold
Price Target: $55
Current: $19.52
Upside: n/a
Aug 5, 2022
Maintained: Buy
Price Target: $15 → $20
Current: $16.03
Upside: n/a
May 11, 2022
Maintained: Sell
Price Target: $5 → $3.9
Current: $7.34
Upside: n/a
May 5, 2022
Maintained: Hold
Price Target: $4 → $3
Current: $1.01
Upside: n/a
Dec 20, 2021
Maintained: Buy
Price Target: n/a
Current: $193.06
Upside: n/a
May 6, 2020
Reiterated: Hold
Price Target: n/a
Current: -
Upside: n/a